Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Abstract

We have identified multiple genetic variants in SLC28A3 and other genes associated with ACT. Combined with clinical risk factors, genetic risk profiling might be used to identify high-risk patients who can then be provided with safer treatment options.